
Expanding expertise across scientific, technical, and operational areas is an important step in supporting the scale-up of innovation and advancing new therapies toward clinical application. As Fetalix continues to grow, the company is strengthening the multidisciplinary team behind the development of its technology.

Strategic investment is essential to support the progression of innovative healthcare technologies toward clinical and commercial application. Early-stage funding enables deep-tech companies to strengthen their capabilities, accelerate technology development, and advance promising innovations toward real-world impact.

Advancing healthcare increasingly relies on collaboration across disciplines and species. The One Health approach recognizes that many biological processes and diseases are shared between humans and animals, creating opportunities for scientific discoveries to generate benefits in both human and veterinary medicine. Events that bring together researchers from these fields play an important role in fostering interdisciplinary collaboration and accelerating innovation.